Cargando…

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation

BACKGROUND: Acetylcholine (ACh) shortens action potential duration (APD) in human atria. APD shortening facilitates atrial fibrillation (AF) by reducing the wavelength for reentry. However, the influence of ACh on electrical conduction in human atria and its contribution to AF are unclear, particula...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayer, Jason D., Boukens, Bastiaan J., Krul, Sébastien P. J., Roney, Caroline H., Driessen, Antoine H. G., Berger, Wouter R., van den Berg, Nicoline W. E., Verkerk, Arie O., Vigmond, Edward J., Coronel, Ruben, de Groot, Joris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737394/
https://www.ncbi.nlm.nih.gov/pubmed/31551802
http://dx.doi.org/10.3389/fphys.2019.01105
_version_ 1783450659351166976
author Bayer, Jason D.
Boukens, Bastiaan J.
Krul, Sébastien P. J.
Roney, Caroline H.
Driessen, Antoine H. G.
Berger, Wouter R.
van den Berg, Nicoline W. E.
Verkerk, Arie O.
Vigmond, Edward J.
Coronel, Ruben
de Groot, Joris R.
author_facet Bayer, Jason D.
Boukens, Bastiaan J.
Krul, Sébastien P. J.
Roney, Caroline H.
Driessen, Antoine H. G.
Berger, Wouter R.
van den Berg, Nicoline W. E.
Verkerk, Arie O.
Vigmond, Edward J.
Coronel, Ruben
de Groot, Joris R.
author_sort Bayer, Jason D.
collection PubMed
description BACKGROUND: Acetylcholine (ACh) shortens action potential duration (APD) in human atria. APD shortening facilitates atrial fibrillation (AF) by reducing the wavelength for reentry. However, the influence of ACh on electrical conduction in human atria and its contribution to AF are unclear, particularly when combined with impaired conduction from interstitial fibrosis. OBJECTIVE: To investigate the effect of ACh on human atrial conduction and its role in AF with computational, experimental, and clinical approaches. METHODS: S1S2 pacing (S1 = 600 ms and S2 = variable cycle lengths) was applied to the following human AF computer models: a left atrial appendage (LAA) myocyte to quantify the effects of ACh on APD, maximum upstroke velocity (V(max)), and resting membrane potential (RMP); a monolayer of LAA myocytes to quantify the effects of ACh on conduction; and 3) an intact left atrium (LA) to determine the effects of ACh on arrhythmogenicity. Heterogeneous ACh and interstitial fibrosis were applied to the monolayer and LA models. To corroborate the simulations, APD and RMP from isolated human atrial myocytes were recorded before and after 0.1 μM ACh. At the tissue level, LAAs from AF patients were optically mapped ex vivo using Di-4-ANEPPS. The difference in total activation time (AT) was determined between AT initially recorded with S1 pacing, and AT recorded during subsequent S1 pacing without (n = 6) or with (n = 7) 100 μM ACh. RESULTS: In LAA myocyte simulations, S1 pacing with 0.1 μM ACh shortened APD by 41 ms, hyperpolarized RMP by 7 mV, and increased V(max) by 27 mV/ms. In human atrial myocytes, 0.1 μM ACh shortened APD by 48 ms, hyperpolarized RMP by 3 mV, and increased V(max) by 6 mV/ms. In LAA monolayer simulations, S1 pacing with ACh hyperpolarized RMP to delay total AT by 32 ms without and 35 ms with fibrosis. This led to unidirectional conduction block and sustained reentry in fibrotic LA with heterogeneous ACh during S2 pacing. In AF patient LAAs, S1 pacing with ACh increased total AT from 39.3 ± 26 ms to 71.4 ± 31.2 ms (p = 0.036) compared to no change without ACh (56.7 ± 29.3 ms to 50.0 ± 21.9 ms, p = 0.140). CONCLUSION: In fibrotic atria with heterogeneous parasympathetic activation, ACh facilitates AF by shortening APD and slowing conduction to promote unidirectional conduction block and reentry.
format Online
Article
Text
id pubmed-6737394
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67373942019-09-24 Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation Bayer, Jason D. Boukens, Bastiaan J. Krul, Sébastien P. J. Roney, Caroline H. Driessen, Antoine H. G. Berger, Wouter R. van den Berg, Nicoline W. E. Verkerk, Arie O. Vigmond, Edward J. Coronel, Ruben de Groot, Joris R. Front Physiol Physiology BACKGROUND: Acetylcholine (ACh) shortens action potential duration (APD) in human atria. APD shortening facilitates atrial fibrillation (AF) by reducing the wavelength for reentry. However, the influence of ACh on electrical conduction in human atria and its contribution to AF are unclear, particularly when combined with impaired conduction from interstitial fibrosis. OBJECTIVE: To investigate the effect of ACh on human atrial conduction and its role in AF with computational, experimental, and clinical approaches. METHODS: S1S2 pacing (S1 = 600 ms and S2 = variable cycle lengths) was applied to the following human AF computer models: a left atrial appendage (LAA) myocyte to quantify the effects of ACh on APD, maximum upstroke velocity (V(max)), and resting membrane potential (RMP); a monolayer of LAA myocytes to quantify the effects of ACh on conduction; and 3) an intact left atrium (LA) to determine the effects of ACh on arrhythmogenicity. Heterogeneous ACh and interstitial fibrosis were applied to the monolayer and LA models. To corroborate the simulations, APD and RMP from isolated human atrial myocytes were recorded before and after 0.1 μM ACh. At the tissue level, LAAs from AF patients were optically mapped ex vivo using Di-4-ANEPPS. The difference in total activation time (AT) was determined between AT initially recorded with S1 pacing, and AT recorded during subsequent S1 pacing without (n = 6) or with (n = 7) 100 μM ACh. RESULTS: In LAA myocyte simulations, S1 pacing with 0.1 μM ACh shortened APD by 41 ms, hyperpolarized RMP by 7 mV, and increased V(max) by 27 mV/ms. In human atrial myocytes, 0.1 μM ACh shortened APD by 48 ms, hyperpolarized RMP by 3 mV, and increased V(max) by 6 mV/ms. In LAA monolayer simulations, S1 pacing with ACh hyperpolarized RMP to delay total AT by 32 ms without and 35 ms with fibrosis. This led to unidirectional conduction block and sustained reentry in fibrotic LA with heterogeneous ACh during S2 pacing. In AF patient LAAs, S1 pacing with ACh increased total AT from 39.3 ± 26 ms to 71.4 ± 31.2 ms (p = 0.036) compared to no change without ACh (56.7 ± 29.3 ms to 50.0 ± 21.9 ms, p = 0.140). CONCLUSION: In fibrotic atria with heterogeneous parasympathetic activation, ACh facilitates AF by shortening APD and slowing conduction to promote unidirectional conduction block and reentry. Frontiers Media S.A. 2019-09-04 /pmc/articles/PMC6737394/ /pubmed/31551802 http://dx.doi.org/10.3389/fphys.2019.01105 Text en Copyright © 2019 Bayer, Boukens, Krul, Roney, Driessen, Berger, van den Berg, Verkerk, Vigmond, Coronel and de Groot. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Bayer, Jason D.
Boukens, Bastiaan J.
Krul, Sébastien P. J.
Roney, Caroline H.
Driessen, Antoine H. G.
Berger, Wouter R.
van den Berg, Nicoline W. E.
Verkerk, Arie O.
Vigmond, Edward J.
Coronel, Ruben
de Groot, Joris R.
Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
title Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
title_full Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
title_fullStr Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
title_full_unstemmed Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
title_short Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
title_sort acetylcholine delays atrial activation to facilitate atrial fibrillation
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737394/
https://www.ncbi.nlm.nih.gov/pubmed/31551802
http://dx.doi.org/10.3389/fphys.2019.01105
work_keys_str_mv AT bayerjasond acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT boukensbastiaanj acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT krulsebastienpj acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT roneycarolineh acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT driessenantoinehg acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT bergerwouterr acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT vandenbergnicolinewe acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT verkerkarieo acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT vigmondedwardj acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT coronelruben acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation
AT degrootjorisr acetylcholinedelaysatrialactivationtofacilitateatrialfibrillation